10.1021/jm101318b
The research investigates the synthesis and cytotoxic properties of novel flavagline analogues with the aim of identifying compounds that could serve as effective anticancer agents. Flavaglines are a class of plant-derived natural products known for their unique anticancer properties, including the ability to inhibit tumor cell proliferation at low nanomolar concentrations without significant toxicity to normal cells. The study explores the structural requirements for cytotoxicity by synthesizing various analogues and examining their effects on different human cancer cell lines. Key chemicals used in the research include rocaglaol (a natural flavagline), FL3 (a synthetic analogue), and various derivatives with modifications at positions C-1, C-2, C-8, and C-40. The researchers found that replacing the hydroxy group at C-1 with an aminoformyl enhanced cytotoxicity and identified compound 18b as particularly effective, reducing tumor growth in a murine allograft model at non-toxic doses. The study concludes that these findings support further preclinical development of flavagline analogues, especially compound 18b, for potential use in cancer treatment.